{
  "id": "Ex006",
  "type": "Example",
  "informationId": {
    "id": "CritAssess280",
    "type": "CriterionAssessment",
    "description": "While the two amino acid changes are not identical, they are the same amino acid change in analagous residues of HRAS and KRAS.",
    "criterion": {
      "id": "PS1",
      "type": "Criterion",
      "description": "Same amino acid change as a previously established pathogenic variant regardless of nucleotide change",
      "defaultStrength": {
        "id": "CG-evidence-strength:ps"
      }
    },
    "variant": {
      "id": "CanAll010",
      "type": "CanonicalAllele",
      "preferredCtxAllele": "CtxAll012",
      "identifier": "http://reg.genome.network/allele/CA341206"
    },
    "condition": [
      {
        "id": "GenCond005",
        "type": "GeneticCondition",
        "disease": [
          {
            "id": "Orphanet:3071",
            "type": "Coding",
            "code": "3071",
            "system": "http://www.orpha.net/",
            "display": "costello syndrome"
          }
        ],
        "modeOfInheritance": {
          "id": "HP:0000006",
          "type": "Coding",
          "code": "0000006",
          "system": "http://human-phenotype-ontology.github.io/",
          "display": "Autosomal Dominant"
        }
      }
    ],
    "outcome": {
      "id": "SEPIO:0000223",
      "type": "Coding",
      "code": "0000223",
      "system": "http://obofoundry.org/sepio/",
      "display": "Met"
    },
    "evidenceLine": [
      {
        "id": "EvLn007",
        "type": "EvidenceLine",
        "evidenceItem": [
          {
            "id": "VarInterp010",
            "type": "VariantInterpretation",
            "description": "NM_004985.4(KRAS):c.173C>T (p.Thr58Ile) Pathogenic for Noonan Syndrome 3",
            "variant": {
              "id": "CanAll011",
              "type": "CanonicalAllele",
              "preferredCtxAllele": "CtxAll014",
              "identifier": "http://reg.genome.network/allele/CA256480"
            },
            "condition": [
              {
                "id": "GenCond006",
                "type": "GeneticCondition",
                "disease": [
                  {
                    "id": "OMIM:609942",
                    "type": "Coding",
                    "code": "609942",
                    "system": "http://www.omim.org/",
                    "display": "noonan syndrome 3"
                  }
                ]
              }
            ],
            "outcome": {
              "id": "LN:LA6668-3",
              "type": "Coding",
              "code": "LA6668-3",
              "system": "http://loinc.org/",
              "display": "Pathogenic"
            }
          }
        ]
      },
      {
        "id": "EvLn008",
        "type": "EvidenceLine",
        "evidenceItem": [
          {
            "id": "VarInterp011",
            "type": "VariantInterpretation",
            "description": "NM_004985.4(KRAS):c.173C>T (p.Thr58Ile) Pathogenic for Costello syndrome",
            "variant": {
              "id": "CanAll011",
              "type": "CanonicalAllele",
              "preferredCtxAllele": "CtxAll014",
              "identifier": "http://reg.genome.network/allele/CA256480"
            },
            "condition": [
              {
                "id": "GenCond055",
                "type": "GeneticCondition",
                "disease": [
                  {
                    "id": "Orphanet:648",
                    "type": "Coding",
                    "code": "648",
                    "system": "http://www.orpha.net/",
                    "display": "noonan syndrome"
                  }
                ],
                "modeOfInheritance": {
                  "id": "HP:0000006",
                  "type": "Coding",
                  "code": "0000006",
                  "system": "http://human-phenotype-ontology.github.io/",
                  "display": "Autosomal Dominant"
                }
              }
            ],
            "outcome": {
              "id": "LN:LA6668-3",
              "type": "Coding",
              "code": "LA6668-3",
              "system": "http://loinc.org/",
              "display": "Pathogenic"
            }
          }
        ]
      }
    ],
    "contribution": [
      {
        "type": "Contribution",
        "agent": {
          "id": "Agent001",
          "type": "Agent",
          "label": "Harry Stevenson"
        },
        "contributionDate": "6/2/16 5:22 PM",
        "contributionRole": {
          "id": "CC303",
          "type": "CodeableConcept",
          "coding": [
            {
              "id": "SEPIO:0000154",
              "type": "Coding",
              "code": "0000154",
              "system": "http://obofoundry.org/sepio/",
              "display": "assessor role"
            }
          ]
        }
      },
      {
        "type": "Contribution",
        "agent": {
          "id": "Agent002",
          "type": "Agent",
          "label": "Noonan/Rasopathy WG (ClinGen)"
        },
        "contributionDate": "6/2/16 5:22 PM",
        "contributionRole": {
          "id": "CC304",
          "type": "CodeableConcept",
          "coding": [
            {
              "id": "SEPIO:0000154",
              "type": "Coding",
              "code": "0000154",
              "system": "http://obofoundry.org/sepio/",
              "display": "assessor role"
            }
          ]
        }
      }
    ]
  },
  "index": 3,
  "author": "Steven Harrison",
  "description": "The Noonan WG decided PS1 was applicable for the same analogous residue positions/regions in highly analogous grouping (HRAS/KRAS/NRAS and MAP2K1/MAP2K2).  So HRAS c.173C>T - p.Thr58Ile [g.533883G>A (chr11, GRCh37)] could use KRAS c.173C>T - p.Thr58Ile [g.25380285G>A (chr12, GRCh37)] and vice versa"
}
